As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

(Reuters) -Moderna posted a smaller-than-expected quarterly loss and reduced its annual operating expenses outlook by $700 million on Thursday, helped by lower production costs and a cutback in ...

The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of ...

Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...

Moderna is getting $54 million to develop a bird flu vaccine after the U.S. government canceled a much larger contract. The Coalition for Epidemic Preparedness Innovations will fund a phase three ...

Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe." Hughes’ comments came as the company opened a 150 ...

A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan 11, 2021. [Photo/Agencies] ...